Neogen (NEOG) Competitors $5.60 +0.11 (+1.91%) Closing price 03:59 PM EasternExtended Trading$5.58 -0.02 (-0.36%) As of 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEOG vs. HAE, ICUI, XRAY, QDEL, STAA, CERS, OSUR, UTMD, ANIK, and WSTShould you be buying Neogen stock or one of its competitors? The main competitors of Neogen include Haemonetics (HAE), ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), STAAR Surgical (STAA), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), and West Pharmaceutical Services (WST). These companies are all part of the "health care supplies" industry. Neogen vs. Its Competitors Haemonetics ICU Medical DENTSPLY SIRONA QuidelOrtho STAAR Surgical Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Neogen (NASDAQ:NEOG) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk. Is NEOG or HAE more profitable? Haemonetics has a net margin of 12.32% compared to Neogen's net margin of -53.56%. Haemonetics' return on equity of 26.37% beat Neogen's return on equity.Company Net Margins Return on Equity Return on Assets Neogen-53.56% 2.69% 1.82% Haemonetics 12.32%26.37%9.22% Do analysts rate NEOG or HAE? Neogen currently has a consensus target price of $7.50, indicating a potential upside of 33.81%. Haemonetics has a consensus target price of $97.30, indicating a potential upside of 24.28%. Given Neogen's higher possible upside, analysts clearly believe Neogen is more favorable than Haemonetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Neogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Haemonetics 1 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has more risk and volatility, NEOG or HAE? Neogen has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.39, suggesting that its share price is 61% less volatile than the S&P 500. Which has better valuation and earnings, NEOG or HAE? Haemonetics has higher revenue and earnings than Neogen. Neogen is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeogen$906.00M1.34-$9.42M-$2.23-2.51Haemonetics$1.36B2.76$167.68M$3.3123.65 Does the media prefer NEOG or HAE? In the previous week, Haemonetics had 2 more articles in the media than Neogen. MarketBeat recorded 9 mentions for Haemonetics and 7 mentions for Neogen. Haemonetics' average media sentiment score of 1.27 beat Neogen's score of 0.11 indicating that Haemonetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neogen 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Haemonetics 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in NEOG or HAE? 96.7% of Neogen shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 1.1% of Neogen shares are owned by insiders. Comparatively, 1.8% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryHaemonetics beats Neogen on 15 of the 17 factors compared between the two stocks. Get Neogen News Delivered to You Automatically Sign up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NEOG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEOG vs. The Competition Export to ExcelMetricNeogenMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22B$10.50B$5.57B$9.02BDividend YieldN/A2.09%5.25%4.03%P/E Ratio-2.5116.5327.2120.15Price / Sales1.3427.87416.26185.35Price / Cash5.1122.7937.0657.97Price / Book0.393.758.085.60Net Income-$9.42M$235.43M$3.16B$248.50M7 Day Performance5.26%3.85%3.74%5.11%1 Month Performance-4.02%4.03%3.88%7.58%1 Year Performance-63.05%-9.88%34.26%21.53% Neogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEOGNeogen4.0972 of 5 stars$5.61+1.9%$7.50+33.8%-62.7%$1.22B$906.00M-2.512,110HAEHaemonetics4.6992 of 5 stars$74.77+1.3%$96.80+29.5%-7.7%$3.59B$1.36B22.593,023News CoveragePositive NewsAnalyst UpgradeAnalyst RevisionICUIICU Medical4.5355 of 5 stars$132.15+0.3%$192.67+45.8%+12.9%$3.25B$2.38B-34.5015,000Positive NewsXRAYDENTSPLY SIRONA4.4467 of 5 stars$15.88-0.3%$20.36+28.2%-31.5%$3.16B$3.79B-3.5014,000QDELQuidelOrtho4.4527 of 5 stars$28.82-0.2%$44.33+53.8%+5.2%$1.95B$2.78B-5.806,600STAASTAAR Surgical3.8389 of 5 stars$16.78-0.8%$24.63+46.8%-58.7%$831.11M$313.90M-11.651,211CERSCerus3.222 of 5 stars$1.41-0.7%$3.50+148.2%-24.7%$269.54M$180.27M-14.10290Positive NewsOSUROraSure Technologies1.8231 of 5 stars$3.00-0.3%$3.00-26.1%$224.40M$185.83M-7.14840News CoverageUTMDUtah Medical Products1.6504 of 5 stars$56.92-1.5%N/A-13.4%$184.99M$40.90M15.06180News CoverageANIKAnika Therapeutics3.7544 of 5 stars$10.58-1.5%$20.00+89.0%-57.1%$151.72M$119.91M-2.73300Positive NewsWSTWest Pharmaceutical Services4.7561 of 5 stars$218.800.0%$320.00+46.3%-29.0%$15.72B$2.89B34.3510,600 Related Companies and Tools Related Companies HAE Competitors ICUI Competitors XRAY Competitors QDEL Competitors STAA Competitors CERS Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEOG) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neogen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Neogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEOG Stock Alerts